Nuveen Asset Management, LLC Century Therapeutics, Inc. Transaction History
Nuveen Asset Management, LLC
- $334 Billion
- Q2 2024
A detailed history of Nuveen Asset Management, LLC transactions in Century Therapeutics, Inc. stock. As of the latest transaction made, Nuveen Asset Management, LLC holds 105,650 shares of IPSC stock, worth $170,096. This represents 0.0% of its overall portfolio holdings.
Number of Shares
105,650
Previous 60,039
75.97%
Holding current value
$170,096
Previous $250,000
7.6%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding IPSC
# of Institutions
61Shares Held
35MCall Options Held
7KPut Options Held
300-
Bain Capital Life Sciences Investors, LLC Boston, MA5.41MShares$8.71 Million2.82% of portfolio
-
Vr Adviser, LLC New York, NY5.39MShares$8.68 Million1.51% of portfolio
-
Boxer Capital, LLC San Diego, CA4.9MShares$7.89 Million0.69% of portfolio
-
Casdin Capital, LLC New York, NY3.21MShares$5.16 Million0.71% of portfolio
-
Black Rock Inc. New York, NY2.9MShares$4.66 Million0.0% of portfolio
About Century Therapeutics, Inc.
- Ticker IPSC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 58,881,800
- Market Cap $94.8M
- Description
- Century Therapeutics, Inc., a biotechnology company, develops transformative allogeneic cell therapies for the treatment of solid tumor and hematological malignancies. The company's lead product candidate is CNTY-101, an allogeneic, induced pluripotent stem cells (iPSCs)-derived chimeric antigen receptors (CAR)-iNK cell therapy targeting CD19 fo...